it actually faired OK on nasdaq, over 4m adr's traded - 48m common shares, mental that it dropped so much on nasdaq really, but market conditions were against it, really thought 110 was a cert though with 130 as an outside chance...balls who wants a guess at what next?/
yeah, it was quick and before nasdaq, shame, but thats how it goes..still very positive, a different day could of seen a higher push, just too early, bio just almost touched year low, which brexit didnt help, but its not the primary reason as it is down trending imo due to Hillary Clinton / Trump and their desire to bring pharma pricing to realistic levels for medcare or whatever its called. also a new analyst put out a 83.31 PT which was the price before the news..they like to **** on our bonfire at times..
Datafeed and UK data supplied by NBTrader and Digital Look.
While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.